Matrine protects against experimental autoimmune encephalomyelitis through modulating microglial ferroptosis
Multiple sclerosis (MS) is an inflammatory demyelination neurodegenerative disease of the central nervous system (CNS). Ferroptosis has been implicated in a range of brain disorders, and iron-loaded microglia are frequently found in affected brain regions. However, the molecular mechanisms linking f...
Gespeichert in:
Veröffentlicht in: | Biochemical and biophysical research communications 2024-11, Vol.735, p.150651, Article 150651 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | 150651 |
container_title | Biochemical and biophysical research communications |
container_volume | 735 |
creator | Feng, Furui Li, Xinyu Wang, Wenbin Dou, Mengmeng Li, Silu Jin, Xin Chu, Yaojuan Zhu, Lin |
description | Multiple sclerosis (MS) is an inflammatory demyelination neurodegenerative disease of the central nervous system (CNS). Ferroptosis has been implicated in a range of brain disorders, and iron-loaded microglia are frequently found in affected brain regions. However, the molecular mechanisms linking ferroptosis with MS have not been well-defined. The present study seeks to bridge this gap and investigate the impact of matrine (MAT), a herbal medicine with immunomodulatory capacities, on the regulation of oxidative stress and ferroptosis in the CNS of mice with experimental autoimmune encephalomyelitis (EAE), an animal model of MS. CNS of EAE mice contained elevated levels of ferroptosis-related molecules, e.g., MDA, LPCAT3 and PTGS2, but decreased expression of antioxidant molecules, including GSH and SOD, GPX4 and SLC7A11. This pathogenic process was reversed by MAT treatment, together with significant reduction of disease severity and CNS inflammatory demyelination. Furthermore, the expression of PTGS2 and LOX was largely increased in microglia of EAE mice, accompanied with increased production of IL-6 and TNF-α, indicating a proinflammatory phenotype of microglia that undergo oxidative stress/ferroptosis, and their expression was significantly reduced after MAT treatment. Together, our results indicate that ferroptosis/inflammation plays an important role in the pathogenesis of CNS autoimmunity, and inhibiting ferroptosis-induced microglial activation/inflammation could be a novel mechanism underlying the therapeutic effects of MAT on CNS inflammatory demyelination in EAE.
•Multiple indicators of ferroptosis have been validated to occur in the EAE model, providing a basis for potential therapeutic targets for multiple sclerosis.•Matrine repairs the SLC7A11-GPX4 axis damage induced by the EAE model.•Matrine mitigated oxidative stress and attenuated inflammation in an EAE model.•Matrine can inhibit lipid peroxidation and protect microglia from ferroptosis in EAE model. |
doi_str_mv | 10.1016/j.bbrc.2024.150651 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3154159323</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X24011872</els_id><sourcerecordid>3103445590</sourcerecordid><originalsourceid>FETCH-LOGICAL-c270t-b31390b5f71a909c3ba4859c028bc6020ca82749ac3871acd26bac6ff9c86a663</originalsourceid><addsrcrecordid>eNqNkU1P3DAURS1UBMPHH2CBsuwmw7OdeGKJDUK0RaLqBiR2luO8zHjkxKntVPDv69FMWaKu3ubcK717CLmisKRAxc122bbBLBmwaklrEDU9IgsKEkpGofpCFgAgSibp6yk5i3ELQGkl5Ak55ZIJ4JwviPupU7AjFlPwCU2KhV5rO8ZU4NuEwQ44Ju0KPSdvh2HOII4Gp412fnhHZ5ONRdoEP683xeC72elkx3UxWBP82tkc7TEEPyUfbbwgx712ES8P95y8fHt4vv9RPv36_nh_91QatoJUtpxyCW3dr6iWIA1vddXU0gBrWiOAgdENW1VSG95kxHRMtNqIvpemEVoIfk6-7nvzU79njEkNNhp0To_o56g4rStaS874f6DAq6quJWSU7dH8WowBezXlfXR4VxTUTojaqp0QtROi9kJy6PrQP7cDdh-RfwYycLsHMA_yx2JQ0djdxp0N2YfqvP2s_y8SKZ7R</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3103445590</pqid></control><display><type>article</type><title>Matrine protects against experimental autoimmune encephalomyelitis through modulating microglial ferroptosis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Feng, Furui ; Li, Xinyu ; Wang, Wenbin ; Dou, Mengmeng ; Li, Silu ; Jin, Xin ; Chu, Yaojuan ; Zhu, Lin</creator><creatorcontrib>Feng, Furui ; Li, Xinyu ; Wang, Wenbin ; Dou, Mengmeng ; Li, Silu ; Jin, Xin ; Chu, Yaojuan ; Zhu, Lin</creatorcontrib><description>Multiple sclerosis (MS) is an inflammatory demyelination neurodegenerative disease of the central nervous system (CNS). Ferroptosis has been implicated in a range of brain disorders, and iron-loaded microglia are frequently found in affected brain regions. However, the molecular mechanisms linking ferroptosis with MS have not been well-defined. The present study seeks to bridge this gap and investigate the impact of matrine (MAT), a herbal medicine with immunomodulatory capacities, on the regulation of oxidative stress and ferroptosis in the CNS of mice with experimental autoimmune encephalomyelitis (EAE), an animal model of MS. CNS of EAE mice contained elevated levels of ferroptosis-related molecules, e.g., MDA, LPCAT3 and PTGS2, but decreased expression of antioxidant molecules, including GSH and SOD, GPX4 and SLC7A11. This pathogenic process was reversed by MAT treatment, together with significant reduction of disease severity and CNS inflammatory demyelination. Furthermore, the expression of PTGS2 and LOX was largely increased in microglia of EAE mice, accompanied with increased production of IL-6 and TNF-α, indicating a proinflammatory phenotype of microglia that undergo oxidative stress/ferroptosis, and their expression was significantly reduced after MAT treatment. Together, our results indicate that ferroptosis/inflammation plays an important role in the pathogenesis of CNS autoimmunity, and inhibiting ferroptosis-induced microglial activation/inflammation could be a novel mechanism underlying the therapeutic effects of MAT on CNS inflammatory demyelination in EAE.
•Multiple indicators of ferroptosis have been validated to occur in the EAE model, providing a basis for potential therapeutic targets for multiple sclerosis.•Matrine repairs the SLC7A11-GPX4 axis damage induced by the EAE model.•Matrine mitigated oxidative stress and attenuated inflammation in an EAE model.•Matrine can inhibit lipid peroxidation and protect microglia from ferroptosis in EAE model.</description><identifier>ISSN: 0006-291X</identifier><identifier>ISSN: 1090-2104</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/j.bbrc.2024.150651</identifier><identifier>PMID: 39260333</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alkaloids - pharmacology ; Alkaloids - therapeutic use ; animal models ; Animals ; antioxidants ; autoimmunity ; brain ; disease severity ; EAE ; encephalitis ; Encephalomyelitis, Autoimmune, Experimental - drug therapy ; Encephalomyelitis, Autoimmune, Experimental - metabolism ; Encephalomyelitis, Autoimmune, Experimental - pathology ; Female ; Ferroptosis ; Ferroptosis - drug effects ; herbal medicines ; Inflammation ; interleukin-6 ; Matrine ; Matrines ; Mice ; Mice, Inbred C57BL ; Microglia - drug effects ; Microglia - metabolism ; Microglia - pathology ; neurodegenerative diseases ; neuroglia ; Oxidative stress ; Oxidative Stress - drug effects ; pathogenesis ; phenotype ; Quinolizines - pharmacology ; Quinolizines - therapeutic use ; sclerosis ; therapeutics</subject><ispartof>Biochemical and biophysical research communications, 2024-11, Vol.735, p.150651, Article 150651</ispartof><rights>2024 Elsevier Inc.</rights><rights>Copyright © 2024 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c270t-b31390b5f71a909c3ba4859c028bc6020ca82749ac3871acd26bac6ff9c86a663</cites><orcidid>0009-0007-4640-7470</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006291X24011872$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39260333$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Feng, Furui</creatorcontrib><creatorcontrib>Li, Xinyu</creatorcontrib><creatorcontrib>Wang, Wenbin</creatorcontrib><creatorcontrib>Dou, Mengmeng</creatorcontrib><creatorcontrib>Li, Silu</creatorcontrib><creatorcontrib>Jin, Xin</creatorcontrib><creatorcontrib>Chu, Yaojuan</creatorcontrib><creatorcontrib>Zhu, Lin</creatorcontrib><title>Matrine protects against experimental autoimmune encephalomyelitis through modulating microglial ferroptosis</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>Multiple sclerosis (MS) is an inflammatory demyelination neurodegenerative disease of the central nervous system (CNS). Ferroptosis has been implicated in a range of brain disorders, and iron-loaded microglia are frequently found in affected brain regions. However, the molecular mechanisms linking ferroptosis with MS have not been well-defined. The present study seeks to bridge this gap and investigate the impact of matrine (MAT), a herbal medicine with immunomodulatory capacities, on the regulation of oxidative stress and ferroptosis in the CNS of mice with experimental autoimmune encephalomyelitis (EAE), an animal model of MS. CNS of EAE mice contained elevated levels of ferroptosis-related molecules, e.g., MDA, LPCAT3 and PTGS2, but decreased expression of antioxidant molecules, including GSH and SOD, GPX4 and SLC7A11. This pathogenic process was reversed by MAT treatment, together with significant reduction of disease severity and CNS inflammatory demyelination. Furthermore, the expression of PTGS2 and LOX was largely increased in microglia of EAE mice, accompanied with increased production of IL-6 and TNF-α, indicating a proinflammatory phenotype of microglia that undergo oxidative stress/ferroptosis, and their expression was significantly reduced after MAT treatment. Together, our results indicate that ferroptosis/inflammation plays an important role in the pathogenesis of CNS autoimmunity, and inhibiting ferroptosis-induced microglial activation/inflammation could be a novel mechanism underlying the therapeutic effects of MAT on CNS inflammatory demyelination in EAE.
•Multiple indicators of ferroptosis have been validated to occur in the EAE model, providing a basis for potential therapeutic targets for multiple sclerosis.•Matrine repairs the SLC7A11-GPX4 axis damage induced by the EAE model.•Matrine mitigated oxidative stress and attenuated inflammation in an EAE model.•Matrine can inhibit lipid peroxidation and protect microglia from ferroptosis in EAE model.</description><subject>Alkaloids - pharmacology</subject><subject>Alkaloids - therapeutic use</subject><subject>animal models</subject><subject>Animals</subject><subject>antioxidants</subject><subject>autoimmunity</subject><subject>brain</subject><subject>disease severity</subject><subject>EAE</subject><subject>encephalitis</subject><subject>Encephalomyelitis, Autoimmune, Experimental - drug therapy</subject><subject>Encephalomyelitis, Autoimmune, Experimental - metabolism</subject><subject>Encephalomyelitis, Autoimmune, Experimental - pathology</subject><subject>Female</subject><subject>Ferroptosis</subject><subject>Ferroptosis - drug effects</subject><subject>herbal medicines</subject><subject>Inflammation</subject><subject>interleukin-6</subject><subject>Matrine</subject><subject>Matrines</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Microglia - drug effects</subject><subject>Microglia - metabolism</subject><subject>Microglia - pathology</subject><subject>neurodegenerative diseases</subject><subject>neuroglia</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>pathogenesis</subject><subject>phenotype</subject><subject>Quinolizines - pharmacology</subject><subject>Quinolizines - therapeutic use</subject><subject>sclerosis</subject><subject>therapeutics</subject><issn>0006-291X</issn><issn>1090-2104</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1P3DAURS1UBMPHH2CBsuwmw7OdeGKJDUK0RaLqBiR2luO8zHjkxKntVPDv69FMWaKu3ubcK717CLmisKRAxc122bbBLBmwaklrEDU9IgsKEkpGofpCFgAgSibp6yk5i3ELQGkl5Ak55ZIJ4JwviPupU7AjFlPwCU2KhV5rO8ZU4NuEwQ44Ju0KPSdvh2HOII4Gp412fnhHZ5ONRdoEP683xeC72elkx3UxWBP82tkc7TEEPyUfbbwgx712ES8P95y8fHt4vv9RPv36_nh_91QatoJUtpxyCW3dr6iWIA1vddXU0gBrWiOAgdENW1VSG95kxHRMtNqIvpemEVoIfk6-7nvzU79njEkNNhp0To_o56g4rStaS874f6DAq6quJWSU7dH8WowBezXlfXR4VxTUTojaqp0QtROi9kJy6PrQP7cDdh-RfwYycLsHMA_yx2JQ0djdxp0N2YfqvP2s_y8SKZ7R</recordid><startdate>20241126</startdate><enddate>20241126</enddate><creator>Feng, Furui</creator><creator>Li, Xinyu</creator><creator>Wang, Wenbin</creator><creator>Dou, Mengmeng</creator><creator>Li, Silu</creator><creator>Jin, Xin</creator><creator>Chu, Yaojuan</creator><creator>Zhu, Lin</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><orcidid>https://orcid.org/0009-0007-4640-7470</orcidid></search><sort><creationdate>20241126</creationdate><title>Matrine protects against experimental autoimmune encephalomyelitis through modulating microglial ferroptosis</title><author>Feng, Furui ; Li, Xinyu ; Wang, Wenbin ; Dou, Mengmeng ; Li, Silu ; Jin, Xin ; Chu, Yaojuan ; Zhu, Lin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c270t-b31390b5f71a909c3ba4859c028bc6020ca82749ac3871acd26bac6ff9c86a663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Alkaloids - pharmacology</topic><topic>Alkaloids - therapeutic use</topic><topic>animal models</topic><topic>Animals</topic><topic>antioxidants</topic><topic>autoimmunity</topic><topic>brain</topic><topic>disease severity</topic><topic>EAE</topic><topic>encephalitis</topic><topic>Encephalomyelitis, Autoimmune, Experimental - drug therapy</topic><topic>Encephalomyelitis, Autoimmune, Experimental - metabolism</topic><topic>Encephalomyelitis, Autoimmune, Experimental - pathology</topic><topic>Female</topic><topic>Ferroptosis</topic><topic>Ferroptosis - drug effects</topic><topic>herbal medicines</topic><topic>Inflammation</topic><topic>interleukin-6</topic><topic>Matrine</topic><topic>Matrines</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Microglia - drug effects</topic><topic>Microglia - metabolism</topic><topic>Microglia - pathology</topic><topic>neurodegenerative diseases</topic><topic>neuroglia</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>pathogenesis</topic><topic>phenotype</topic><topic>Quinolizines - pharmacology</topic><topic>Quinolizines - therapeutic use</topic><topic>sclerosis</topic><topic>therapeutics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Feng, Furui</creatorcontrib><creatorcontrib>Li, Xinyu</creatorcontrib><creatorcontrib>Wang, Wenbin</creatorcontrib><creatorcontrib>Dou, Mengmeng</creatorcontrib><creatorcontrib>Li, Silu</creatorcontrib><creatorcontrib>Jin, Xin</creatorcontrib><creatorcontrib>Chu, Yaojuan</creatorcontrib><creatorcontrib>Zhu, Lin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Feng, Furui</au><au>Li, Xinyu</au><au>Wang, Wenbin</au><au>Dou, Mengmeng</au><au>Li, Silu</au><au>Jin, Xin</au><au>Chu, Yaojuan</au><au>Zhu, Lin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Matrine protects against experimental autoimmune encephalomyelitis through modulating microglial ferroptosis</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2024-11-26</date><risdate>2024</risdate><volume>735</volume><spage>150651</spage><pages>150651-</pages><artnum>150651</artnum><issn>0006-291X</issn><issn>1090-2104</issn><eissn>1090-2104</eissn><abstract>Multiple sclerosis (MS) is an inflammatory demyelination neurodegenerative disease of the central nervous system (CNS). Ferroptosis has been implicated in a range of brain disorders, and iron-loaded microglia are frequently found in affected brain regions. However, the molecular mechanisms linking ferroptosis with MS have not been well-defined. The present study seeks to bridge this gap and investigate the impact of matrine (MAT), a herbal medicine with immunomodulatory capacities, on the regulation of oxidative stress and ferroptosis in the CNS of mice with experimental autoimmune encephalomyelitis (EAE), an animal model of MS. CNS of EAE mice contained elevated levels of ferroptosis-related molecules, e.g., MDA, LPCAT3 and PTGS2, but decreased expression of antioxidant molecules, including GSH and SOD, GPX4 and SLC7A11. This pathogenic process was reversed by MAT treatment, together with significant reduction of disease severity and CNS inflammatory demyelination. Furthermore, the expression of PTGS2 and LOX was largely increased in microglia of EAE mice, accompanied with increased production of IL-6 and TNF-α, indicating a proinflammatory phenotype of microglia that undergo oxidative stress/ferroptosis, and their expression was significantly reduced after MAT treatment. Together, our results indicate that ferroptosis/inflammation plays an important role in the pathogenesis of CNS autoimmunity, and inhibiting ferroptosis-induced microglial activation/inflammation could be a novel mechanism underlying the therapeutic effects of MAT on CNS inflammatory demyelination in EAE.
•Multiple indicators of ferroptosis have been validated to occur in the EAE model, providing a basis for potential therapeutic targets for multiple sclerosis.•Matrine repairs the SLC7A11-GPX4 axis damage induced by the EAE model.•Matrine mitigated oxidative stress and attenuated inflammation in an EAE model.•Matrine can inhibit lipid peroxidation and protect microglia from ferroptosis in EAE model.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>39260333</pmid><doi>10.1016/j.bbrc.2024.150651</doi><orcidid>https://orcid.org/0009-0007-4640-7470</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-291X |
ispartof | Biochemical and biophysical research communications, 2024-11, Vol.735, p.150651, Article 150651 |
issn | 0006-291X 1090-2104 1090-2104 |
language | eng |
recordid | cdi_proquest_miscellaneous_3154159323 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Alkaloids - pharmacology Alkaloids - therapeutic use animal models Animals antioxidants autoimmunity brain disease severity EAE encephalitis Encephalomyelitis, Autoimmune, Experimental - drug therapy Encephalomyelitis, Autoimmune, Experimental - metabolism Encephalomyelitis, Autoimmune, Experimental - pathology Female Ferroptosis Ferroptosis - drug effects herbal medicines Inflammation interleukin-6 Matrine Matrines Mice Mice, Inbred C57BL Microglia - drug effects Microglia - metabolism Microglia - pathology neurodegenerative diseases neuroglia Oxidative stress Oxidative Stress - drug effects pathogenesis phenotype Quinolizines - pharmacology Quinolizines - therapeutic use sclerosis therapeutics |
title | Matrine protects against experimental autoimmune encephalomyelitis through modulating microglial ferroptosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T20%3A22%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Matrine%20protects%20against%20experimental%20autoimmune%20encephalomyelitis%20through%20modulating%20microglial%20ferroptosis&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Feng,%20Furui&rft.date=2024-11-26&rft.volume=735&rft.spage=150651&rft.pages=150651-&rft.artnum=150651&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/j.bbrc.2024.150651&rft_dat=%3Cproquest_cross%3E3103445590%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3103445590&rft_id=info:pmid/39260333&rft_els_id=S0006291X24011872&rfr_iscdi=true |